Broadridge Financial Solutions (BR)

NYSEIndustrialsInformation Technology ServicesSnapshot 2026-10-15

$175.11+0.57%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Broadridge Financial Solutions’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.0%

+10% or more+5%0%−5%−10% or less

11.56 → 11.56 EPS · FY ending Jun 30, 2028 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Adjusted EPS growth between 10% and 12% annually	Adjusted EPS rises 10% to 12% annually.	Intact	Adjusted EPS growth falls below 9% YoY in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Adjusted EPS increased from $8.55 in fiscal 2025 to $9.60 in fiscal 2026, a 12% rise. Fiscal 2027 guidance targets 8-12% Adjusted EPS growth. The trajectory shows consistent delivery of EPS growth aligned with management's guidance. Delivery assessment Oct 15, 2026
Closed sales between $290M and $330M	A supporting condition in Broadridge Financial Solutions's published investment case. The stated target is $290M to $330M.	Intact	Closed sales fall below $280M in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Closed sales rose from $288 million in fiscal 2025 to $305 million in fiscal 2026. Fiscal 2027 guidance targets Closed sales between $290 million and $330 million. The trajectory shows strong sales performance consistent with management's stated goals. Delivery assessment Oct 15, 2026
Recurring revenue growth at or above 7% annually	A primary condition in Broadridge Financial Solutions's published investment case. The stated target is >=7% YoY.	Intact	Recurring revenue growth falls below 6% YoY in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Recurring revenues grew from $4.508B in fiscal 2025 to $4.878B in fiscal 2026, an 8% increase constant currency. Fiscal 2027 guidance calls for 6-8% recurring revenue growth constant currency. The trajectory is delivering consistent growth aligned with management's stated targets. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-06-30 · fmp

FY2028 EPS$11.56

$11.37 → $11.56 · observed estimates

FY2028 revenue$8.23B

$8.16B → $8.23B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$11.37	$8,159,629,842	6 / 7
2026-07-25	$11.37	$8,159,629,842	6 / 7
2026-07-26	$11.37	$8,159,629,842	6 / 7
2026-07-27	$11.37	$8,159,629,842	6 / 7
2026-07-28	$11.38	$8,159,646,508	6 / 7
2026-07-29	$11.38	$8,159,646,508	6 / 7
2026-07-30	$11.38	$8,159,646,508	6 / 7
2026-07-31	$11.38	$8,159,646,508	6 / 7
2026-08-01	$11.38	$8,159,646,508	6 / 7
2026-08-02	$11.38	$8,159,646,508	6 / 7
2026-08-03	$11.38	$8,159,646,508	6 / 7
2026-08-04	$11.38	$8,159,646,508	6 / 7
2026-08-05	$11.54	$8,242,411,290	8 / 7
2026-08-06	$11.54	$8,242,411,290	8 / 7
2026-08-07	$11.56	$8,235,738,402	6 / 6
2026-08-08	$11.58	$8,249,043,439	9 / 9
2026-08-09	$11.58	$8,249,043,439	9 / 9
2026-08-10	$11.58	$8,249,043,439	9 / 9
2026-08-11	$11.58	$8,249,043,439	9 / 9
2026-08-12	$11.58	$8,249,043,439	9 / 9
2026-08-13	$11.56	$8,235,738,402	6 / 6
2026-08-14	$11.56	$8,235,738,402	6 / 6
2026-08-15	$11.56	$8,235,738,402	7 / 7
2026-08-16	$11.56	$8,235,738,402	7 / 7
2026-08-17	$11.56	$8,235,738,402	7 / 7
2026-08-18	$11.56	$8,235,738,402	7 / 7
2026-08-19	$11.56	$8,235,738,402	7 / 7
2026-08-20	$11.56	$8,228,534,755	7 / 7
2026-08-21	$11.56	$8,228,534,755	7 / 7
2026-08-22	$11.56	$8,228,534,755	7 / 7
2026-08-23	$11.56	$8,228,534,755	7 / 7
2026-08-24	$11.56	$8,228,534,755	7 / 7
2026-08-25	$11.56	$8,228,534,755	7 / 7
2026-08-26	$11.56	$8,228,534,755	7 / 7
2026-08-27	$11.56	$8,228,534,755	7 / 7
2026-08-28	$11.56	$8,228,534,755	7 / 7
2026-08-29	$11.56	$8,228,534,755	7 / 7
2026-08-30	$11.56	$8,228,534,755	7 / 7
2026-08-31	$11.56	$8,228,534,755	7 / 7
2026-09-01	$11.56	$8,228,534,755	7 / 7
2026-09-02	$11.56	$8,228,534,755	7 / 7
2026-09-03	$11.56	$8,228,534,755	7 / 7
2026-09-04	$11.56	$8,228,534,755	7 / 7
2026-09-05	$11.56	$8,228,534,755	7 / 7
2026-09-06	$11.56	$8,228,534,755	7 / 7
2026-09-07	$11.56	$8,228,534,755	7 / 7
2026-09-08	$11.56	$8,228,534,755	7 / 7
2026-09-09	$11.56	$8,228,534,755	7 / 7
2026-09-10	$11.56	$8,228,534,755	7 / 7
2026-09-11	$11.56	$8,228,534,755	7 / 7
2026-09-12	$11.56	$8,228,534,755	7 / 7
2026-09-13	$11.56	$8,228,534,755	7 / 7
2026-09-14	$11.56	$8,228,534,755	7 / 7
2026-09-15	$11.56	$8,228,534,755	7 / 7
2026-09-16	$11.56	$8,228,534,755	7 / 7
2026-09-17	$11.56	$8,228,534,755	7 / 7
2026-09-18	$11.56	$8,228,534,755	7 / 7
2026-09-19	$11.56	$8,228,534,755	7 / 7
2026-09-20	$11.56	$8,228,534,755	7 / 7
2026-09-21	$11.56	$8,228,534,755	7 / 7
2026-09-22	$11.56	$8,228,534,755	7 / 7
2026-09-23	$11.56	$8,228,534,755	7 / 7
2026-09-24	$11.56	$8,228,534,755	7 / 7
2026-09-25	$11.56	$8,228,534,755	7 / 7
2026-09-26	$11.56	$8,228,534,755	7 / 7
2026-09-27	$11.56	$8,228,534,755	7 / 7
2026-09-28	$11.56	$8,228,534,755	7 / 7
2026-09-29	$11.56	$8,228,534,755	7 / 7
2026-09-30	$11.56	$8,228,534,755	7 / 7
2026-10-01	$11.56	$8,228,534,755	7 / 7
2026-10-02	$11.56	$8,228,534,755	7 / 7
2026-10-03	$11.56	$8,228,534,755	7 / 7
2026-10-04	$11.56	$8,228,534,755	7 / 7
2026-10-05	$11.56	$8,228,534,755	7 / 7
2026-10-06	$11.56	$8,228,534,755	7 / 7
2026-10-07	$11.56	$8,228,534,755	7 / 7
2026-10-08	$11.56	$8,228,534,755	7 / 7
2026-10-09	$11.56	$8,229,634,755	7 / 7
2026-10-10	$11.56	$8,229,634,755	7 / 7
2026-10-11	$11.56	$8,229,634,755	7 / 7
2026-10-12	$11.56	$8,229,634,755	7 / 7
2026-10-13	$11.56	$8,229,634,755	7 / 7
2026-10-14	$11.56	$8,229,634,755	7 / 7
2026-10-15	$11.56	$8,229,634,755	7 / 7

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	5	4
2026-06-01	5	4
2026-07-01	5	4
2026-08-01	6	4
2026-09-01	5	4
2026-10-01	5	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 5 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 16–Oct 15 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EPS growth between 10% and 12% annuallyDirect metric needs a verified mapping
Closed sales between $290M and $330MDirect metric needs a verified mapping
Recurring revenue growth at or above 7% annuallyDirect metric needs a verified mapping

Next proof point

Nov 3, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.2%Typical daily move · historical

Downside history

-41.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Broadridge Financial Solutions outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on consistent revenue and earnings growth. The current thesis state is intact, supported by strong recent financial results and management's commitment to growth targets.

What's priced into Broadridge Financial Solutions

The market appears to have priced in a neutral valuation, with BR being seen as cheap compared to its peers. There is a slight expectations gap, indicating that investors may not fully anticipate the potential for growth in recurring revenue and adjusted earnings per share.

What the fundamentals likely do

Management has shown strong execution in increasing recurring revenue and adjusted EPS, with guidance suggesting continued growth. However, there is a near-term risk of missing earnings expectations, given the recent performance of industry peers.

What Broadridge Financial Solutions hinges on

The long-term thesis hinges on the performance of sector bellwethers like LDOS, CACI, and G. If these companies continue to exceed earnings expectations, it could provide a favorable backdrop for BR. Conversely, any negative guidance from these peers could pose risks to BR's momentum.